JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

HDAC

B1141 Varenicline Hydrochloride

Summary: α4β2 nicotinic receptor agonist

Soluble in DMSO
A9906 HDAC Set I

Summary: For inhibiting HDAC
A8806 TMP269

Summary: HDAC 4/5/7/9 inhibitor

≥23 mg/mL
A8803 RGFP966
4 Citation

Target: Histone Deacetylases (HDACs)

Summary: Specific HDAC3 inhibitor

insoluble in H2O; ≥18.12 mg/mL
A8547 Tubastatin A HCl
1 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent and selective

insoluble in EtOH; ≥12.34 mg/mL
A8183 Trichostatin A (TSA)
28 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; ≥15.12 mg/mL
A8178 Panobinostat (LBH589)
22 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
A8176 Apicidin
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Potent HDAC inhibitor

soluble in DMSO or ethanol
A8173 Romidepsin (FK228, depsipeptide)
7 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC1/HDAC2 inhibitor, potent and selective

≥27.04 mg/mL
A8171 Entinostat (MS-275,SNDX-275)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC1 and HDAC3 inhibitor

insoluble in H2O; ≥18.8 mg/mL